Who Exports Lapatinib from India — 86 Suppliers Behind a $5.4M Market
India's lapatinib export market is supplied by 86 active exporters who collectively shipped $5.4M across 300 shipments. NATCO PHARMA LIMITED leads with a 55.4% market share, followed by BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED and MEDWISE OVERSEAS PRIVATE LIMITED. The top 5 suppliers together control 92.8% of total export value, reflecting a concentrated market structure.
Top Lapatinib Exporters from India — Ranked by Export Value
NATCO PHARMA LIMITED is the leading lapatinib exporter from India, holding a 55.4% share of the $5.4M market across 300 shipments from 86 exporters. The top 5 suppliers — NATCO PHARMA LIMITED, BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED, MEDWISE OVERSEAS PRIVATE LIMITED, MBA PHARMACEUTICALS PRIVATE LIMITED, IKRIS PHARMA NETWORK PRIVATE LIMITED — collectively control 92.8% of total export value, indicating a highly concentrated market. Individual shares are: NATCO PHARMA LIMITED (55.4%), BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED (35.7%), MEDWISE OVERSEAS PRIVATE LIMITED (0.9%), MBA PHARMACEUTICALS PRIVATE LIMITED (0.5%), IKRIS PHARMA NETWORK PRIVATE LIMITED (0.4%).
Top Lapatinib Exporters from India
Ranked by export value · 86 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | NATCO PHARMA LIMITED LAPATINIB 250MG, TABLETS 150S NOSLAPATINIB 250 MG TABLETSTABLETS : LAPATINIB 250 MG 150'S | $3.0M | 4 | 55.4% |
| 2 | BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED LAPATINIB TABLETS 250MGLAPATINIB 250MG FILM COATED TAB (OLAPATINIB AS DISTOSYLATE MONOHYDRATE 2 | $1.9M | 4 | 35.7% |
| 3 | MEDWISE OVERSEAS PRIVATE LIMITED LAPATIMED 250 ,LAPATIMED 250BN.BTLAPATIMED-250 | $47.2K | 1 | 0.9% |
| 4 | MBA PHARMACEUTICALS PRIVATE LIMITED TYKENIB 250MG - LAPATINIB TABLETS IP 25TYKENIB 250MGMEDICINE FOR HUMAN USE LAPATINIB TABLETSIP 250MG | $25.7K | 3 | 0.5% |
| 5 | IKRIS PHARMA NETWORK PRIVATE LIMITED | $20.0K | 1 | 0.4% |
| 6 | SHREE KRISHNA LIFECARE | $18.5K | 1 | 0.3% |
| 7 | BETA DRUGS LIMITED LAPATIMED 250 ,LAPATIMED 250BN.BTLAPATIMED-250 | $17.3K | 2 | 0.3% |
| 8 | CAPLIN POINT LABORATORIES LIMITED | $17.1K | 2 | 0.3% |
| 9 | HEET HEALTHCARE PRIVATE LIMITED | $11.8K | 3 | 0.2% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Lapatinib exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| NATCO PHARMA LIMITED | Approved | Yes | Yes | Multiple | FDA-approved for multiple ANDAs; WHO-GMP and EU GMP certified. |
| BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED | Not Listed | Yes | Yes | Not verified | WHO-GMP and EU GMP certified; no FDA listing found. |
| MEDWISE OVERSEAS PRIVATE LIMITED | Not Listed | Unknown | Unknown | Not verified | No specific regulatory certifications found. |
| MBA PHARMACEUTICALS PRIVATE LIMITED | Not Listed | Unknown | Unknown | Not verified | No specific regulatory certifications found. |
| IKRIS PHARMA NETWORK PRIVATE LIMITED | Not Listed | Unknown | Unknown | Not verified | No specific regulatory certifications found. |
| SHREE KRISHNA LIFECARE | Not Listed | Unknown | Unknown | Not verified | No specific regulatory certifications found. |
| BETA DRUGS LIMITED | Not Listed | Unknown | Unknown | Not verified | No specific regulatory certifications found. |
| CAPLIN POINT LABORATORIES LIMITED | Approved | Yes | Yes | Multiple | FDA-approved for multiple ANDAs; WHO-GMP and EU GMP certified. |
| HEET HEALTHCARE PRIVATE LIMITED | Not Listed | Unknown | Unknown | Not verified | No specific regulatory certifications found. |
TransData Nexus reviewed the regulatory standing of 9 leading Lapatinib exporters from India. 2 hold US FDA facility approvals, 3 maintain WHO-GMP certification, and 3 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Lapatinib sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," is a pivotal center for pharmaceutical manufacturing. The city contributes approximately 40% of the country's bulk drug production, underscoring its significance in the pharmaceutical sector. This prominence is bolstered by the presence of Hyderabad Pharma City, an ambitious industrial development aimed at creating the world's largest integrated pharmaceutical ecosystem. The project encompasses manufacturing, research and development (R&D), logistics, and commercial hubs, positioning Hyderabad as a global leader in pharma and biotech innovation.
Notably, Natco Pharma Limited, headquartered in Hyderabad, is a major producer of Lapatinib, accounting for $3.0 million (55.4%) of the total exports. The city's robust infrastructure and supportive government policies have attracted numerous pharmaceutical companies, further solidifying its status as a bulk drug manufacturing hub.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. Gujarat leads India with a 33% share in drug manufacturing and a 28% share in drug exports. The state hosts 130 USFDA-certified drug manufacturing facilities, with Ahmedabad and Vadodara emerging as prominent pharmaceutical hubs.
Vadodara is home to Alembic Pharmaceuticals, one of India's oldest pharmaceutical companies, established in 1907. The city's pharmaceutical landscape includes both large-scale industries and numerous small and medium enterprises, contributing to its reputation as a major hub in Gujarat's pharmaceutical industry.
In the context of Lapatinib exports, BDR Pharmaceuticals International Private Limited, based in Vadodara, plays a significant role, contributing $1.9 million (35.7%) to the total exports. The region's emphasis on formulations and its extensive manufacturing capabilities make it a critical player in the pharmaceutical export market.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a crucial export gateway for India's pharmaceutical products. Mumbai, being the financial capital, offers unparalleled connectivity and infrastructure, facilitating efficient export operations. The region hosts numerous pharmaceutical companies, including major exporters, leveraging the logistical advantages to distribute products globally.
While specific data on Lapatinib exports from this region is not detailed, the area's strategic location and established export channels contribute significantly to India's pharmaceutical export capabilities.
4Baddi-Nalagarh — Tax Incentive Zone
The Baddi-Nalagarh region in Himachal Pradesh has emerged as a prominent pharmaceutical manufacturing zone, primarily due to favorable tax incentives offered by the government. These incentives have attracted numerous pharmaceutical companies to set up manufacturing units in the area, contributing to its rapid industrial growth.
Although specific contributions to Lapatinib exports from this region are not highlighted, the area's overall impact on India's pharmaceutical manufacturing landscape is noteworthy.
5Sourcing Recommendations
- Diversify Supplier Base: While Natco Pharma Limited and BDR Pharmaceuticals International Private Limited are major contributors to Lapatinib exports, exploring partnerships with other manufacturers in different regions can mitigate supply chain risks.
- Leverage Regional Specializations: Engage with suppliers in Hyderabad for bulk drug requirements and collaborate with firms in the Ahmedabad-Vadodara corridor for formulation needs, capitalizing on each region's strengths.
- Assess Export Logistics: Utilize the Mumbai-Thane-Raigad region's export infrastructure to streamline international shipments, ensuring timely and efficient delivery.
- Monitor Regulatory Compliance: Ensure that all suppliers adhere to international quality standards and regulatory requirements, maintaining the integrity and safety of the pharmaceutical products.
By strategically engaging with these pharmaceutical clusters and adhering to these recommendations, TransData Nexus can optimize its supply chain for Lapatinib, ensuring reliability and efficiency in its operations.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Lapatinib exporters from India
NATCO PHARMA LIMITED — Natco Pharma to Evaluate Demerger of Agro Business
Natco Pharma's Board approved an in-principle decision to evaluate the demerger of its Agro business into a separate entity, aiming to unlock value in its core pharmaceutical operations and enhance long-term growth. - IMPACT: This strategic move is expected to allow Natco Pharma to concentrate more resources on its pharmaceutical segment, potentially strengthening its position in Lapatinib exports.
Impact: This strategic move is expected to allow Natco Pharma to concentrate more resources on its pharmaceutical segment, potentially strengthening its position in Lapatinib exports.
Common Questions — Lapatinib Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which lapatinib supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, NATCO PHARMA LIMITED leads with 22 recorded shipments worth $3.0M. BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED (12 shipments) and MEDWISE OVERSEAS PRIVATE LIMITED (3 shipments) are also established high-volume exporters.
Q How many lapatinib manufacturers are there in India?
India has 86 active lapatinib exporters with a combined export market of $5.4M across 300 shipments to 49 countries. The top 5 suppliers hold 92.8% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for lapatinib from India?
Average FOB unit price: $49.67 per unit, ranging from $0.00 to $2410.95. Average shipment value: $17.8K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 86 verified Indian exporters of Lapatinib ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 300 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 49 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
300 Verified Shipments
86 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists